Published: 19-12-2022
Review
Chylothorax associated with sarcoidosis: a review of the literature
Abstract 320 | PDF Downloads 263 | DOI https://doi.org/10.36141/svdld.v39i4.12050Page e2022039
Original Articles: Clinical Research
Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF
Abstract 350 | PDF Downloads 289 | DOI https://doi.org/10.36141/svdld.v39i4.11344Page e2022035
Infliximab decreases inflammatory activity but has no effect on small fiber neuropathy related symptoms in Dutch patients with sarcoidosis
Abstract 348 | PDF Downloads 36 | DOI https://doi.org/10.36141/svdld.v39i4.12031Page e2022033
Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
Abstract 474 | PDF Downloads 386 | DOI https://doi.org/10.36141/svdld.v39i4.13682Page e2022038
Role of computed tomography findings, complete blood count parameters and systemic inflammatory markers for predicting the severity in interstitial lung diseases
Abstract 434 | PDF Downloads 288 | DOI https://doi.org/10.36141/svdld.v39i4.11616Page e2022042
Original Articles: Laboratory Research
Metagenomic sequencing of the bronchoalveolar lavage extracellular virome and cellular transcriptome of sarcoidosis patients does not detect rubella virus
Abstract 315 | PDF Downloads 260 | DOI https://doi.org/10.36141/svdld.v39i4.13407Page e2022040
Case Reports
A case of hepatic and bone marrow sarcoidosis with progressive renal failure: diagnostic and therapeutic challenges
Abstract 294 | PDF Downloads 261 | DOI https://doi.org/10.36141/svdld.v39i4.11350Page e2022041
Letter to Editor
Management of high-degree atrioventricular block in the setting of cardiac sarcoidosis: A therapeutic controversy
Abstract 299 | PDF Downloads 240 | DOI https://doi.org/10.36141/svdld.v39i4.13721Page e2022036
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis
Abstract 252 | PDF Downloads 230 | DOI https://doi.org/10.36141/svdld.v39i4.13372Page e2022037